New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
AstraZeneca PLC
AZN.L
Shape
US Flag

LSE

184B

Drug Manufacturers - General

Next Earning date - 11 Nov 2024

184B

Drug Manufacturers - General

Next Earning date - 11 Nov 2024

11868.00GBP
Shape4.00 ( 0.03%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-99%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

11%

Quote Panel

Shape
Updated October 23, 2024
1W -1.38 % 1M 2.92 % 3M -2.32 % 1Y 15.39 %

Key Metrics

Shape
  • Market Cap

    183.99B


  • Shares Outstanding

    1.55B


  • Share in Float

    1.46B


  • Dividende

    234


  • Earning Date

    11 Nov 2024


  • Price Target

    11868


  • Average Volume

    1.91M


  • Beta

    0.166


  • Range

    9461.0-13388.0


  • Industry

    Drug Manufacturers - General


  • Website

    https://www.astrazeneca.com


  • Sector

    Healthcare


Fundamentals

Shape

1642.38x

P/E Ratio

4.83x

P/S Ratio

6.02x

P/B Ratio

0.8

Debt/Equity

13.1%

Net Margin

$3.2

EPS

How AZN.L compares to sector?

P/E Ratio

Relative Strength

Shape

AZN.L

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$56B

Shape335%

2025-Revenue

$8.26

Shape566%

2025-EPS

$15B

Shape260%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+55%

1.67
vs 1.08

Q4.22

arrow
arrow

-17%

1.38
vs 1.67

Q1.23

arrow
arrow

+2%

1.92
vs 1.89

Q2.23

arrow
arrow

+25%

2.15
vs 1.72

Q3.23

arrow
arrow

+4%

1.73
vs 1.67

Q4.23

arrow
arrow

+5%

1.45
vs 1.38

Q1.24

arrow
arrow

+7%

2.06
vs 1.92

Q2.24

arrow
arrow

-8%

1.98
vs 2.15

Q3.24

arrow
arrow

+19%

2.06
vs 1.73

Q4.24

arrow
arrow

+36%

1.97
vs 1.45

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+11%

11B  vs 9.9B

Q4.22

arrow
arrow

-7%

11.2B  vs 12B

Q1.23

arrow
arrow

-4%

10.9B  vs 11.4B

Q2.23

arrow
arrow

+6%

11.4B  vs 10.8B

Q3.23

arrow
arrow

+5%

11.5B  vs 11B

Q4.23

arrow
arrow

+7%

12B  vs 11.2B

Q1.24

arrow
arrow

+17%

12.7B  vs 10.9B

Q2.24

arrow
arrow

+13%

12.9B  vs 11.4B

Q3.24

arrow
arrow

+14%

13.1B  vs 11.5B

Q4.24

arrow
arrow

+11%

13.4B  vs 12B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+5%

0.05
vs 0.01

Q4.22

arrow
arrow

+2%

0.02
vs 0.05

Q1.23

arrow
arrow

+5%

0.05
vs 0.02

Q2.23

arrow
arrow

+5%

0.05
vs 0.05

Q3.23

arrow
arrow

+4%

0.04
vs 0.05

Q4.23

arrow
arrow

+2%

0.02
vs 0.04

Q1.24

arrow
arrow

+6%

0.06
vs 0.02

Q2.24

arrow
arrow

+5%

0.05
vs 0.06

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News